ATE65401T1 - Stabile, injizierbare loesungen von salzen von vincristin. - Google Patents

Stabile, injizierbare loesungen von salzen von vincristin.

Info

Publication number
ATE65401T1
ATE65401T1 AT88103072T AT88103072T ATE65401T1 AT E65401 T1 ATE65401 T1 AT E65401T1 AT 88103072 T AT88103072 T AT 88103072T AT 88103072 T AT88103072 T AT 88103072T AT E65401 T1 ATE65401 T1 AT E65401T1
Authority
AT
Austria
Prior art keywords
salts
stable
vincristin
injectable solutions
pharmaceutically acceptable
Prior art date
Application number
AT88103072T
Other languages
English (en)
Inventor
Rodney Kasan
Michael Seiffe
Haim Yellin
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE65401T1 publication Critical patent/ATE65401T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88103072T 1987-07-06 1988-03-01 Stabile, injizierbare loesungen von salzen von vincristin. ATE65401T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL83086A IL83086A (en) 1987-07-06 1987-07-06 Stable,injectable solutions of vincristine salts
EP88103072A EP0298192B1 (de) 1987-07-06 1988-03-01 Stabile, injizierbare Lösungen von Salzen von Vincristin

Publications (1)

Publication Number Publication Date
ATE65401T1 true ATE65401T1 (de) 1991-08-15

Family

ID=11057953

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88103072T ATE65401T1 (de) 1987-07-06 1988-03-01 Stabile, injizierbare loesungen von salzen von vincristin.

Country Status (8)

Country Link
US (1) US4883805A (de)
EP (1) EP0298192B1 (de)
JP (1) JPS6416724A (de)
AT (1) ATE65401T1 (de)
CA (1) CA1303992C (de)
DE (1) DE3863859D1 (de)
ES (1) ES2028917T3 (de)
IL (1) IL83086A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
US6849655B2 (en) 2000-05-15 2005-02-01 Kissei Pharmaceutical Co., Ltd. Aqueous liquid formulations
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
CN104383542B (zh) 2003-04-08 2017-09-26 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
US7923037B2 (en) * 2006-10-05 2011-04-12 Ikaria, Inc. Liquid chalcogenide compositions and methods of manufacturing and using the same
JP6099557B2 (ja) * 2013-12-27 2017-03-22 富士フイルム株式会社 注射液製剤及びその製造方法
JP6823045B2 (ja) 2015-08-01 2021-01-27 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． ビンカアルカロイド薬の投薬形態
CN114699369A (zh) * 2022-05-19 2022-07-05 青岛农业大学 一种盐酸溴己新注射液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248291A (en) * 1963-08-19 1966-04-26 Hoffmann La Roche Stabilized thioxanthene derivatives and method of using the same
GB1254057A (en) * 1969-04-24 1971-11-17 Louisette Olivier Improvements in or relating to therapeutical composition containing vincamine
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4708962A (en) * 1984-12-17 1987-11-24 Harbor Branch Oceanographic Institution, Inc. Antiviral and antitumor cyclohexadienone compositions
US4707498A (en) * 1986-01-14 1987-11-17 Merrell Dow Pharmaceuticals Inc. Fluorinated diaminoalkyne derivatives

Also Published As

Publication number Publication date
CA1303992C (en) 1992-06-23
US4883805A (en) 1989-11-28
EP0298192B1 (de) 1991-07-24
AU1257888A (en) 1989-01-12
ES2028917T3 (es) 1992-07-16
JPS6416724A (en) 1989-01-20
JPH0525857B2 (de) 1993-04-14
IL83086A0 (en) 1987-12-31
EP0298192A1 (de) 1989-01-11
IL83086A (en) 1991-03-10
DE3863859D1 (de) 1991-08-29
AU604094B2 (en) 1990-12-06

Similar Documents

Publication Publication Date Title
DZ1067A1 (fr) Nouvelles préparations pharmaceutiques à emission prolongée.
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
DE69111205D1 (de) Stabilisierung von Calcitonin enthaltenden pharmazeutischen Verbindungen.
ATE126438T1 (de) Stabile injizierbare pharmazeutische formulation mit folinsäure und leukovorinsalze und verfahren.
FR2681863B1 (fr) Solution de sparfloxacine sa preparation et sel la constituant.
NO902488D0 (no) Karboplatinapreparat.
AR245591A1 (es) Una composicion oral estable, con propiedades antiplaca y antigingivales mejoradas.
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
ATE117313T1 (de) Stabile lösungen von rebeccamycinderivaten sowie deren herstellung.
KR880008995A (ko) 2-알킬설피닐-4(3h)-퀴나졸리논 유도체, 이의 제조방법 및 약학적 조성물
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee